» Articles » PMID: 22545762

Efficacy of Codelivery of Dual AAV2/5 Vectors in the Murine Retina and Hippocampus

Overview
Journal Hum Gene Ther
Specialties Genetics
Pharmacology
Date 2012 May 2
PMID 22545762
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Recombinant adeno-associated virus (AAV) represents an efficient system for neuronal transduction. However, a potential drawback of AAV is its restricted packaging capacity of approximately 5 kb. To bypass this limitation, a number of dual- and triple-vector strategies divide the transgene(s) between two or three AAVs. The success of these approaches relies directly on efficient cotransduction of the component AAVs. Although proof of concept for these stratagems has been demonstrated, the underlying cotransduction rate has not been analyzed quantitatively. In this study, cotransduction efficiencies in both retina and hippocampus have been investigated, using two reporter AAVs expressing either a green (GFP) or red (DsR) fluorescent protein. Transduction efficiencies were monitored via microscopy, flow cytometry, and quantitative PCR. After viral transduction with 1.5×10(9) viral particles of each of the reporter AAVs, approximately one-third of the retinal cells expressed one or both transgenes at levels detectable by native fluorescence. Notably, the majority of the remaining retinal cells were also transduced and expressed the reporters at lower levels, which were detectable only by immunolabeling. Flow cytometric analysis demonstrated cotransduction rates of up to 55% with the two reporter AAVs in retinal cells. Modifying the ratio of the two coadministered AAVs resulted in altered mRNA expression levels of the two reporter genes in cotransduced cell populations. The study suggests that codelivery of AAV is an efficient means of expanding the therapeutic application of AAV in neurons.

Citing Articles

Gene therapy for CNS disorders: modalities, delivery and translational challenges.

Gao J, Gunasekar S, Xia Z, Shalin K, Jiang C, Chen H Nat Rev Neurosci. 2024; 25(8):553-572.

PMID: 38898231 DOI: 10.1038/s41583-024-00829-7.


Cell-Specific Single Viral Vector CRISPR/Cas9 Editing and Genetically Encoded Tool Delivery in the Central and Peripheral Nervous Systems.

Moffa J, Bland I, Tooley J, Kalyanaraman V, Heitmeier M, Creed M eNeuro. 2024; 11(7).

PMID: 38871457 PMC: 11228695. DOI: 10.1523/ENEURO.0438-23.2024.


Engineering of the AAV-Compatible Hair Cell-Specific Small-Size Myo15 Promoter for Gene Therapy in the Inner Ear.

Hu S, Lv J, Wang Z, Tang H, Wang H, Wang F Research (Wash D C). 2024; 7:0341.

PMID: 38665848 PMC: 11045262. DOI: 10.34133/research.0341.


Understanding capsid assembly and genome packaging for adeno-associated viruses.

Bennett A, Mietzsch M, Agbandje-Mckenna M Future Virol. 2023; 12(6):283-297.

PMID: 36776482 PMC: 9910337. DOI: 10.2217/fvl-2017-0011.


Novel tool to quantify with single-cell resolution the number of incoming AAV genomes co-expressed in the mouse nervous system.

Maturana C, Verpeut J, Kooshkbaghi M, Engel E Gene Ther. 2021; 30(5):463-468.

PMID: 34176926 PMC: 10191834. DOI: 10.1038/s41434-021-00272-8.